Suppr超能文献

肿瘤浸润性 IL-17 产生细胞在食管鳞癌中的积累和预后价值。

The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma.

机构信息

State Key Laboratory of Oncology in Southern China and Department of Experimental Research, Cancer Center, Sun Yat-sen University, Guangzhou, People's Republic of China.

出版信息

PLoS One. 2011 Mar 31;6(3):e18219. doi: 10.1371/journal.pone.0018219.

Abstract

BACKGROUND

The role of IL-17 producing cells in tumors is controversial. In the present study, we investigated the prognostic value of measuring tumor-infiltrating IL-17 producing cell levels in human esophageal squamous cell carcinoma (ESCC).

METHODOLOGY/PRINCIPAL FINDINGS: Immunohistochemical staining was performed to investigate the levels of IL-17+ tumor infiltrating lymphocytes (TILs), as well as CD8+ cytotoxic T lymphocytes (CTLs) and CD57+ natural killer (NK) cells from 181 ESCC patients. The prognostic value of measuring the densities of IL-17+TILs and the correlation with CTLs and NK was evaluated. IL-17 producing cells were detected in esophageal squamous cell carcinoma tissues. The IL-17 producing cells were major CD4 positive, but Foxp3 negative. The median level of IL-17+TILs was 3.90 cells/high power microscopic field (HPF). The density of IL-17 producing cells correlated negatively with T stage (P=0.042). The higher densities of tumor infiltrating IL-17+ lymphocytes were associated with better overall survival (P=0.031). Furthermore, we found that there were positive correlations between levels of IL-17 producing cells and the densities of CD8+cells, as well as CD57+cells (r=0.198, P=0.008 for CD8+ cells and r=0.261, P<0.001 for CD57+ cells, respectively). The prognosis analysis also showed that the higher levels of CD8+ CTLs and CD57+ NK cells correlated with better overall survival of ESCC patients.

CONCLUSIONS

Our study suggests that tumor infiltrating IL-17 producing cells in ESCC patients may have protective roles in the tumor microenvironment and may be treated as a prognostic marker for ESCC patients.

摘要

背景

白细胞介素 17(IL-17)产生细胞在肿瘤中的作用存在争议。本研究旨在探讨人食管鳞状细胞癌(ESCC)中肿瘤浸润性 IL-17 产生细胞水平的预后价值。

方法/主要发现:对 181 例 ESCC 患者的肿瘤浸润性 IL-17+肿瘤浸润淋巴细胞(TILs)、CD8+细胞毒性 T 淋巴细胞(CTL)和 CD57+自然杀伤(NK)细胞水平进行免疫组织化学染色。评估了测量 IL-17+TILs 密度的预后价值以及与 CTLs 和 NK 的相关性。在食管鳞状细胞癌组织中检测到 IL-17 产生细胞。这些细胞主要为 CD4+阳性,但 Foxp3 阴性。IL-17+TILs 的中位数为 3.90 个高倍镜视野(HPF)。IL-17 产生细胞的密度与 T 分期呈负相关(P=0.042)。肿瘤浸润性 IL-17+淋巴细胞密度较高与总生存率提高相关(P=0.031)。此外,我们发现 IL-17 产生细胞水平与 CD8+细胞和 CD57+细胞密度之间存在正相关(r=0.198,P=0.008 用于 CD8+细胞;r=0.261,P<0.001 用于 CD57+细胞)。预后分析还表明,较高水平的 CD8+CTL 和 CD57+NK 细胞与 ESCC 患者的总生存率提高相关。

结论

本研究表明,ESCC 患者肿瘤浸润性 IL-17 产生细胞可能在肿瘤微环境中具有保护作用,并可作为 ESCC 患者的预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/16d5/3069054/8622d73a3095/pone.0018219.g001.jpg

相似文献

5
Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma.
Esophagus. 2019 Oct;16(4):333-344. doi: 10.1007/s10388-019-00669-w. Epub 2019 Apr 9.
6
IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma.
Cancer Immunol Immunother. 2020 Nov;69(11):2371-2380. doi: 10.1007/s00262-020-02629-1. Epub 2020 Jun 10.

引用本文的文献

2
The role of interleukin-17 in inflammation-related cancers.
Front Immunol. 2025 Jan 21;15:1479505. doi: 10.3389/fimmu.2024.1479505. eCollection 2024.
4
Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma.
Sci Prog. 2024 Jan-Mar;107(1):368504241237888. doi: 10.1177/00368504241237888.
5
The protective and pathogenic role of Th17 cell plasticity and function in the tumor microenvironment.
Front Immunol. 2023 Jun 29;14:1192303. doi: 10.3389/fimmu.2023.1192303. eCollection 2023.
6
Relationship Between CD8+ T Cells and Prognosis of Esophageal Cancer Patients: A Systematic Review and Meta-analysis.
Mol Biotechnol. 2024 Jan;66(1):138-150. doi: 10.1007/s12033-023-00733-y. Epub 2023 Apr 15.
7
T17 cell heterogeneity and its role in tissue inflammation.
Nat Immunol. 2023 Jan;24(1):19-29. doi: 10.1038/s41590-022-01387-9. Epub 2023 Jan 3.
8
The role of Th17 cells in chronic lymphocytic leukemia: friend or foe?
Blood Adv. 2023 Jun 13;7(11):2401-2417. doi: 10.1182/bloodadvances.2022008985.

本文引用的文献

2
Distinct compartmental distribution of mature and immature dendritic cells in esophageal squamous cell carcinoma.
Pathol Res Pract. 2010 Sep 15;206(9):602-6. doi: 10.1016/j.prp.2010.03.011. Epub 2010 May 23.
4
T(H)17 cells in tumour immunity and immunotherapy.
Nat Rev Immunol. 2010 Apr;10(4):248-56. doi: 10.1038/nri2742.
6
T helper 17 cells promote cytotoxic T cell activation in tumor immunity.
Immunity. 2009 Nov 20;31(5):787-98. doi: 10.1016/j.immuni.2009.09.014. Epub 2009 Oct 29.
7
Gammadelta T cells and Th17 cytokines in hypersensitivity pneumonitis and lung fibrosis.
Transl Res. 2009 Nov;154(5):222-7. doi: 10.1016/j.trsl.2009.08.006. Epub 2009 Sep 9.
8
Expression of FOXP3 in esophageal squamous cell carcinoma relating to the clinical data.
Dis Esophagus. 2010 May;23(4):340-6. doi: 10.1111/j.1442-2050.2009.01013.x. Epub 2009 Sep 24.
9
Protumor vs antitumor functions of IL-17.
J Immunol. 2009 Oct 1;183(7):4169-75. doi: 10.4049/jimmunol.0901017.
10
[Th17 cells in human rheumatoid arthritis].
Nihon Rinsho Meneki Gakkai Kaishi. 2009 Aug;32(4):249-55. doi: 10.2177/jsci.32.249.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验